Krisja Vermeylen
Director/Board Member bei MORPHOSYS AG
Vermögen: 217 728 $ am 31.03.2024
Profil
Krisja Vermeylen is a Member-Supervisory Board at MorphoSys AG since 2017.
Previously, Ms. Vermeylen worked as a Director at Diaverum AB from 2020 to 2023.
Prior to that, Ms. Vermeylen held the position of Senior Vice President-People & Organisation at Novo Nordisk A from 2015 to 2018.
Ms. Vermeylen also served as Vice President & General Manager at Novo Nordisk Pharma GmbH from 2013 to 2015 and as Vice President-Europe West, France & BeLux at Novo Nordisk SAS from 2008 to 2013.
Additionally, Ms. Vermeylen was the General Manager at Novo Nordisk SA (Belgium) from 1998 to 2002 and a Senior Product Manager at Pharmacia & Upjohn from 1996 to 1997.
Ms. Vermeylen obtained a graduate degree from the University of Antwerp in 1985 and a doctorate degree from the same university in 1986.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MORPHOSYS AG
0,01% | 16.02.2024 | 3 000 ( 0,01% ) | 217 728 $ | 31.03.2024 |
Aktive Positionen von Krisja Vermeylen
| Unternehmen | Position | Beginn |
|---|---|---|
| MORPHOSYS AG | Director/Board Member | 01.01.2017 |
Ehemalige bekannte Positionen von Krisja Vermeylen
| Unternehmen | Position | Ende |
|---|---|---|
Diaverum AB
 Diaverum AB Medical/Nursing ServicesHealth Services Diaverum AB engages in the provision of renal care to patients with chronic kidney disease (CKD). It offers hemodialysis, peritoneal dialysis, and kidney transplant. The company was founded by Nils Alwall in 1991 and is headquartered in Malmo, Sweden. | Director/Board Member | 31.12.2023 |
| NOVO NORDISK A/S | Human Resources Officer | 01.01.2018 |
Novo Nordisk Pharma GmbH
 Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Corporate Officer/Principal | 01.01.2015 |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Corporate Officer/Principal | 01.01.2013 |
| Novo Nordisk SA (Belgium) | Corporate Officer/Principal | 01.01.2002 |
Ausbildung von Krisja Vermeylen
| University of Antwerp | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| MORPHOSYS AG | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Health Technology |
Novo Nordisk SAS
Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Health Technology |
Diaverum AB
Diaverum AB Medical/Nursing ServicesHealth Services Diaverum AB engages in the provision of renal care to patients with chronic kidney disease (CKD). It offers hemodialysis, peritoneal dialysis, and kidney transplant. The company was founded by Nils Alwall in 1991 and is headquartered in Malmo, Sweden. | Health Services |
| Novo Nordisk SA (Belgium) | |
Pharmacia & Upjohn
 Pharmacia & Upjohn Pharmaceuticals: MajorHealth Technology Pharmacia & Upjohn is a Belgian company that manufactures pharmaceutical products. The private company is based in Brussels, Belgium. | Health Technology |
